Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

34.17
+0.94002.83%
Post-market: 34.170.00000.00%16:00 EDT
Volume:2.03M
Turnover:69.46M
Market Cap:3.99B
PE:-7.32
High:34.99
Open:33.67
Low:33.43
Close:33.23
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:1.15
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.76
PE(LYR):-10.70

Loading ...

Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 26, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]